Dispersible concentrate for the delivery of cyclosporin

作者: Abraham J. Domb

DOI:

关键词:

摘要: A formulation for the administration of a cyclosporin. This features hydrophilic solvent which is characterized by being lower alkyl ester hydroxyalkanoic acid; and surfactant, preferably combination surfactant with high HLB (hydrophilic/lipophilic balance) at least about 8 low less than 5. Other ingredients are optional, such as fatty acid tricaprin, phospholipid, an ethoxylated fat Cremophor or another similar substance. Optionally, substituted surfactant. The preferred particle size resultant 100 nm, more 60 most from 5 nm to 50 nm. present invention having bioavailability.

参考文章(112)
Robert L. Suddith, Andrew S. Janoff, Lois E. Bolcsak, Alan L. Weiner, Paul A. Tremblay, Michael V. W. Bergamini, Alpha tocopherol-based vesicles ,(1986)
Doron Friedman, Shimon Amselem, Solid fat nanoemulsions as drug delivery vehicles ,(1994)
David R. Hathaway, Robert L. Wilensky, Keith L. March, Composition and method for delivery of drugs ,(1992)
Dieter Seebach, RenéP. Traber, Roland Wenger, Brigitte Besemer-Rosenwirth, Soo Young Ko, Hans Kobel, Pietro Bollinger, Cyclosporin fermentation process ,(1999)
Abraham J. Domb, Manoj Maniar, Liposphere delivery systems for local anesthetics ,(1992)
Vittorio Buran, Gianettore Bocchiola, Ambrogio Magni, Method of isolating cyclosporins ,(1997)
Daniela Lombardi, Luca Dobetti, Luigi Boltri, Pierandrea Esposito, Fabio Carli, Pharmaceutical compositions including a drug, a cross-linked polymeric substance, an oil, and a surface active agent ,(1993)
Christian Merle, Robert Floc'H, Cyclosporin a formulations as nanoparticles ,(1996)
Robert Becker, Bernd Kruss, Rainer H. Muller, Katrin Peters, Pharmaceutical nanosuspensions for medicament administration as systems with increased saturation solubility and speed of dissolution Official Gazette of the United States Patent and Trademark Office Patents. ,vol. 1218, pp. 1181- ,(1995)